Healthy Skepticism Library item: 5724

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Bell TR.
Bromocriptine and drug information
Lancet 1994; 343:297

Abstract:

Information for doctors in the United Kingdom is much delayed compared with the United States and when it does come the associated potential risks are still less emphasized and detailed.

Keywords:
*letter to the editor/United Kingdom/Sandoz/Parlodel/commercial compendia/quality of information/safety & risk information/developed countries/EVALUATION OF PROMOTION: COMMERCIAL DRUG COMPENDIA/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES